Delivery Order SPE2DR25D1202-SPE2DR26F71RR
- Not listed
- The Defense Logistics Agency awarded a $1,349.67 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Esomeprazole Magnesium Delayed Release 40 mg capsules (30-count units). This firm fixed-price contract, with a completion date of September 9, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, demonstrating AmerisourceBergen's capability to...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count units) with a ceiling value of $2,133.12. This delivery order represents a firm fixed-price, non-set-aside award and is scheduled for ultimate completion by September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Esomeprazole Magnesium Delayed Release 40 mg capsules (30-count units) with a ceiling value of $3,199.68. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Esomeprazole Magnesium Delayed Release 40 mg capsules (30-count unit) with a ceiling value of $1,599.84. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competitive procurement. The order is set for ultimate completion by July 31, 2025, and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) valued at $1,066.56. This non-set-aside competitive award reflects a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations...
- The Defense Logistics Agency awarded a delivery order valued at $3,701.91 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed Release 20 mg capsules (90-count) on October 28, 2025, with completion scheduled for October 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) with a ceiling value of $12,297.40. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract performance location is in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, with an ultimate completion date of July...
- The Defense Logistics Agency awarded a delivery order valued at $1,512.92 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count unit). This is a firm fixed price delivery order with no set-aside designation, issued on September 2, 2025, with an ultimate completion date of September 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a firm fixed price ceiling value of $5,752.28. The award was issued on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitive delivery order, which carries no set-aside designation, represents a purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,942.94 to AmerisourceBergen Drug Corp for the supply of esomeprazole magnesium delayed-release 40 mg capsules (30-count units). This order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F71RRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count unit) with a ceiling value of $3,734.00. This firm fixed-price delivery order is scheduled for completion by October 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive capability in federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of drug deliveries to military and veteran healthcare systems. The company's federal contracts demonstrate consistent capability to deliver a broad spectrum of pharmaceutical products, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 10/27/25 |